Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate CancerClin Genitourin Cancer 2021 Oct 01;19(5)447-456, D McHugh, S Tagawa, N Moryl, M Milowsky, G Heller, J Osborne, D Rathkopf, E Basch, N Pandit-Taskar, MJ Morris
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.